JPH0597622A - Production of glass powder for glass ionomer cement - Google Patents
Production of glass powder for glass ionomer cementInfo
- Publication number
- JPH0597622A JPH0597622A JP3285510A JP28551091A JPH0597622A JP H0597622 A JPH0597622 A JP H0597622A JP 3285510 A JP3285510 A JP 3285510A JP 28551091 A JP28551091 A JP 28551091A JP H0597622 A JPH0597622 A JP H0597622A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- glass powder
- glass
- carboxylic acid
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 71
- 239000011521 glass Substances 0.000 title claims abstract description 58
- 239000003178 glass ionomer cement Substances 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 28
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 27
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims description 14
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 238000007711 solidification Methods 0.000 claims description 4
- 230000008023 solidification Effects 0.000 claims description 4
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 238000001028 reflection method Methods 0.000 claims description 2
- 238000004611 spectroscopical analysis Methods 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract description 39
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract description 37
- 239000011975 tartaric acid Substances 0.000 abstract description 37
- 235000002906 tartaric acid Nutrition 0.000 abstract description 37
- 239000004568 cement Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 6
- 239000005354 aluminosilicate glass Substances 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002253 acid Substances 0.000 abstract description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract description 4
- 230000000704 physical effect Effects 0.000 abstract description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract description 4
- 229920002125 Sokalan® Polymers 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 239000004584 polyacrylic acid Substances 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 abstract description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract description 2
- 229960004889 salicylic acid Drugs 0.000 abstract description 2
- 230000002411 adverse Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 229960001367 tartaric acid Drugs 0.000 description 36
- 230000015271 coagulation Effects 0.000 description 11
- 238000005345 coagulation Methods 0.000 description 11
- 239000002245 particle Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000011575 calcium Substances 0.000 description 4
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229910004298 SiO 2 Inorganic materials 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- -1 fluoride ions Chemical class 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229910017119 AlPO Inorganic materials 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229960001270 d- tartaric acid Drugs 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 210000004268 dentin Anatomy 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 2
- 239000002672 zinc phosphate cement Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229910016569 AlF 3 Inorganic materials 0.000 description 1
- 229910004261 CaF 2 Inorganic materials 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- 238000004455 differential thermal analysis Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Dental Preparations (AREA)
- Glass Compositions (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は主に歯科用のグラスアイ
オノマーセメントの粉末成分として利用されるアルミノ
シリケートガラス粉末に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an aluminosilicate glass powder mainly used as a powder component of a dental glass ionomer cement.
【0002】[0002]
【従来技術・課題】歯科用グラスアイオノマーセメント
はアルミノシリケートガラス粉末(以下、ガラス粉末)
とポリアクリル酸などのポリアルケン酸(以下、ポリ
酸)とを水の存在下で練和し、反応硬化させることによ
って得られる。この硬化物は歯髄に対する為害性が低
く、エナメル質や象牙質などの歯質に対してもすぐれた
接着力を有している。さらに硬化物からは長期間に渉
り、微量のフッ素イオンが口腔内で放出されるためエナ
メル質および象牙質に耐ウ蝕性を与える効果が認められ
ている。[Prior Art / Problems] Dental glass ionomer cement is aluminosilicate glass powder (hereinafter referred to as glass powder).
And polyalkenoic acid such as polyacrylic acid (hereinafter referred to as polyacid) are kneaded in the presence of water, and the reaction is cured. This cured product is less harmful to the pulp and has excellent adhesiveness to tooth substances such as enamel and dentin. Further, it has been confirmed that the cured product releases a small amount of fluoride ions in the oral cavity over a long period of time and thus has an effect of imparting caries resistance to enamel and dentin.
【0003】このようにグラスアイオノマーセメント
は、他の歯科用セメント例えばリン酸亜鉛セメントにな
いすぐれた特徴を有するが、このセメントが実際に市場
に広く受け入れられるか否かは、これらの性状以外に
も、破砕抗力、崩壊率、透光性などの理工学的性状は勿
論、これらの性状と同等或いはそれ以上の比重で臨床で
の使い易さ、すなわち操作性が重要視されている。操作
性とは所定の重量比でガラス粉末、ポリ酸、及び水の練
和を開始してからある一定時間までの練和物の諸性状を
表わし、この中には操作時間、硬化(凝固)時間、稠度
などがあり、これらの測定方法などについての規格がJ
ISやBSなどに詳しく定められている。実際の臨床で
は、歯科衛生士や医師が余裕をもって作業を行うために
操作時間は可能な限り長く、逆に口腔内に装入(着)し
てからはすぐに硬化し実用に耐えるセメントが望まれて
いる。As described above, the glass ionomer cement has excellent characteristics that other dental cements such as zinc phosphate cement do not have, but whether or not the cement is actually widely accepted in the market depends on these properties. Of course, not only physical and engineering properties such as crushing resistance, disintegration rate, and translucency, but also easiness in clinical use, that is, operability is emphasized with a specific gravity equal to or higher than these properties. The operability refers to various properties of the kneaded product from the start of kneading the glass powder, the polyacid, and the water at a predetermined weight ratio to a certain period of time, including the operating time and the curing (solidification). There is time, consistency, etc., and the standard for these measuring methods is J
It is defined in detail in IS and BS. In actual clinical practice, dental hygienists and doctors can work with plenty of time, so the operating time is as long as possible, and conversely, cement that can be hardened and put into practical use immediately after being placed (wearing) in the oral cavity is desired. It is rare.
【0004】その故、操作性をより改良するため、多く
の研究がなされてきた。例えば、酒石酸を調整剤として
ポリ酸溶液中に添加し、操作時間を延長させる手法(特
公昭55−8019)、ガラス粉末を酸で洗浄し、粉末
表面に存在する陽イオン、例えばカルシウムイオンを除
去し、ポリ酸との硬化反応を実質的に遅延させる方法
(特公昭59−5536)、ポリ酸溶液にフルオロ錯塩
を添加させる方法(特公昭56−37964)、さらに
ガラスフリットを酒石酸の存在下、乾式にて微粉砕し、
酒石酸とガラス粉末とをメカノ・ケミカル的に処理する
方法(特開昭63−225567)などが提案されてい
る。Therefore, much research has been conducted in order to further improve the operability. For example, tartaric acid as a regulator is added to a polyacid solution to extend the operation time (Japanese Patent Publication No. 55-8019), glass powder is washed with acid to remove cations such as calcium ions present on the powder surface. Then, a method of substantially delaying the curing reaction with a polyacid (JP-B-59-5536), a method of adding a fluoro complex salt to a polyacid solution (JP-B-56-37964), and a glass frit in the presence of tartaric acid, Finely pulverized by dry method,
A method of treating tartaric acid and glass powder mechano-chemically (Japanese Patent Laid-Open No. 225567/1988) has been proposed.
【0005】上述のごとくグラスアイオノマーセメント
の操作性向上のために、数多くの提案がなされてきた
が、未だ十分であるとは言い難い。特に多くの臨床家
(歯科医)は、歴史のあるリン酸亜鉛セメントに習熟し
使い慣れているため、このセメントの操作性と比較する
と不足と考えられ、グラスアイオノマーセメントの普及
を妨げる一因となっている。又、操作性の向上、特に操
作時間の延長化は歯科の分野のみならず、外科ひいては
工業的分野例えば水道工事(漏水対策)や建築内装工事
への適用も可能になり、その利用は大きく広がるものと
期待される。尚、第三成分の単なる添加による方法で
は、これらを多量に加える必要があり、ひいては硬化セ
メントの物性を著しく低下させる原因になりやすい。As described above, many proposals have been made to improve the operability of the glass ionomer cement, but it is still difficult to say that it is sufficient. In particular, many clinicians (dentists) are familiar with zinc phosphate cement with a long history and are used to it, so it is considered to be insufficient compared with the operability of this cement, which is one of the factors that hinder the spread of glass ionomer cement. ing. In addition, the improvement of operability, especially the extension of operation time, can be applied not only to the field of dentistry but also to the field of surgery and industrial fields such as waterworks (leakage countermeasures) and construction work for interior construction. Expected to be. In addition, in the method in which the third component is simply added, it is necessary to add a large amount of these components, which is likely to cause a remarkable decrease in the physical properties of the hardened cement.
【0006】[0006]
【解決手段・作用】本発明者は上述の問題点の解決を目
ざし、ガラス粉末の性状について鋭意研究を進めた結
果、意外にもグラスアイオノマーセメントの粉末成分と
してのガラス粉末をカルボン酸の存在下で単に熱処理す
ることにより、その後のセメント液成分(ポリアルケン
酸)との練和・硬化反応における、操作性が著しく向上
することを見い出し、本発明を完成するに到った。通
常、操作時間を長くしようとすると凝固(硬化)時間も
著しく長くなりJIS規格(T6602)の凝固時間の
上限8分を越えてしまう場合が多い。しかし、本発明に
よれば極めて簡便な処理によって凝固時間をJIS規格
の範囲内に維持しつつ操作時間を大幅に延長できる。
尚、本明細書において操作時間とは英国標準規格“歯科
用グラスアイオノマーセメント”BS6039(198
1)に準拠する。[Means for Solving the Problems] As a result of earnest research on the properties of the glass powder, the present inventor surprisingly solved the above problems, and as a result, surprisingly, the glass powder as a powder component of the glass ionomer cement was treated in the presence of carboxylic acid. It was found that the operability was significantly improved in the subsequent kneading and curing reaction with the cement liquid component (polyalkenoic acid) by simply heat-treating, and the present invention was completed. Usually, when the operation time is increased, the solidification (curing) time also becomes remarkably long, and the upper limit of the solidification time of JIS standard (T6602) often exceeds 8 minutes in many cases. However, according to the present invention, the operation time can be greatly extended while maintaining the coagulation time within the range of JIS standard by an extremely simple process.
In the present specification, the operation time is the British standard “dental glass ionomer cement” BS6039 (198).
Comply with 1).
【0007】本発明は、グラスアイオノマーセメント用
ガラス、即ちグラスアイオノマーセメントの粉末成分と
して使用されるアルミノシリケートガラス粉末に広く適
用可能である。このガラス粉末は、通常、シリカ(Si
O2)、アルミナ(Al2O3)及びカルシウム成分(C
aO)を主成分とし、さらに0〜20wt%のフッ素成
分(F)、0〜10wt%のリン成分(P2O5)、0〜
10wt%のナトリウム成分(Na2O)等が含まれ
る。例えば、特公昭50−24328、同59−553
6を参照されたい。もっとも、これらに限定する趣旨で
はなく、本発明による操作性向上効果が得られる限り、
種々の組成のアルミノシリケートガラス粉末を包含す
る。グラスアイオノマーセメント用ガラスは、常法にし
たがって、例えば次のように製造される。即ち、天然或
いは人工の原料を所定の重量で秤量し、十分に混合す
る。次いで、この混合物を1100℃〜1500℃の高
温で均質に溶解した後、急冷却し、ガラスフリットを作
製する。このガラスフリットは通常の粉砕方法、例えば
ボールミル、振動ミル、ジェットミル等で乾式微粉砕さ
れるが、最終的な粉末粒度は最大でも50μm以下、好
ましくは40μm、合着用に際しては25μm以下にす
るのが望ましい。一方、1μm以下の微粉が多くなる
と、理工学的特性は向上するが操作性等は逆に低下す
る。そして、こうして得られたガラス粉末に本発明のカ
ルボン酸存在下での熱処理を施す。本発明の使用に適す
るガラス粉末は未処理の状態で(本発明による処理をし
ない状態で)、酒石酸を含む市販のポリ酸溶液と練和し
た時、例えば英国規格(BS)6039に定める方法で
操作時間が3分以内、好ましくは2分以内、凝固時間も
7分以内、好ましくは5分以内の特性を示すガラス粉末
に対して、その効果が顕著に発揮される。The present invention is widely applicable to glass for glass ionomer cement, that is, aluminosilicate glass powder used as a powder component of glass ionomer cement. This glass powder is usually silica (Si
O 2 ), alumina (Al 2 O 3 ) and calcium component (C
aO) as a main component, and further contains 0 to 20 wt% of a fluorine component (F), 0 to 10 wt% of a phosphorus component (P 2 O 5 ), 0 to
It contains 10 wt% of sodium component (Na 2 O) and the like. For example, Japanese Examined Patent Publications 50-24328 and 59-553.
See 6. However, it is not intended to be limited to these, as long as the operability improving effect of the present invention is obtained,
It includes aluminosilicate glass powders of various compositions. The glass for glass ionomer cement is manufactured by a conventional method, for example, as follows. That is, a natural or artificial raw material is weighed in a predetermined weight and sufficiently mixed. Next, this mixture is homogeneously melted at a high temperature of 1100 ° C. to 1500 ° C. and then rapidly cooled to prepare a glass frit. The glass frit is dry finely pulverized by an ordinary pulverizing method, for example, a ball mill, a vibration mill, a jet mill, etc., but the final particle size of the powder is 50 μm or less at the maximum, preferably 40 μm, and 25 μm or less for wearing. Is desirable. On the other hand, when the amount of fine powder of 1 μm or less is increased, the physics and engineering characteristics are improved, but the operability and the like are decreased. Then, the glass powder thus obtained is subjected to a heat treatment in the presence of the carboxylic acid of the present invention. Glass powders suitable for use according to the invention are untreated (without treatment according to the invention) when kneaded with a commercially available polyacid solution containing tartaric acid, for example by the method specified in British Standard (BS) 6039. The effect is remarkably exerted on the glass powder showing the characteristics that the operation time is within 3 minutes, preferably within 2 minutes, and the coagulation time is within 7 minutes, preferably within 5 minutes.
【0008】ガラス粉末の熱処理において使用するカル
ボン酸はガラス粉末とポリ酸との初期硬化反応を若干遅
延させることにより、操作性を向上し、反応終期におけ
るセメント硬化物の特性に影響を及ぼさないものを選択
する。カルボン酸は分子内にカルボキシル基(−COO
H)を有する有機酸であり、例えば、カルボキシル基1
個の酢酸、乳酸、サリチル酸、グルコン酸、同2個のシ
ュウ酸、酒石酸、コハク酸、マレイン酸、リンゴ酸、同
3個のクエン酸、同4個のエチレンジアミン四酢酸(E
DTA)酸等が挙げられる。又、これらの混合物であっ
てもよい。性状は固体、液体を問わず、例えば酒石酸、
コハク酸など上記カルボン酸の多くのものが常温にて固
体(粉末)である。粉末の場合、その平均粒径はガラス
粉末と均一な混合状態を少量で効率よく達成するために
は細かい方が好ましく、ガラス粉末の平均粒径以下が望
ましい。The carboxylic acid used in the heat treatment of the glass powder improves the operability by slightly delaying the initial curing reaction between the glass powder and the polyacid, and does not affect the properties of the cement hardened product at the end of the reaction. Select. Carboxylic acid has a carboxyl group (-COO in the molecule).
H) is an organic acid having a carboxyl group 1
Acetic acid, lactic acid, salicylic acid, gluconic acid, 2 oxalic acid, tartaric acid, succinic acid, maleic acid, malic acid, 3 citric acid, 4 ethylenediaminetetraacetic acid (E
DTA) acid and the like. Also, a mixture of these may be used. The property is solid or liquid, for example, tartaric acid,
Many of the above carboxylic acids such as succinic acid are solid (powder) at room temperature. In the case of powder, the average particle size is preferably fine in order to efficiently achieve a uniform mixed state with the glass powder with a small amount, and is preferably equal to or smaller than the average particle size of the glass powder.
【0009】こうした固体又は液体カルボン酸の所定量
をガラス粉末に添加して、両者を混合する。ガラス粉末
とカルボン酸との混合はV型やリボン型の混合機を用い
ても可能であるが、カルボン酸が粉末の場合、粉体間の
比重差や出発粒径が違うため十分に混合するには、せん
断力、或いは衝撃力を伴う振動ミル、ボールミルなどを
利用するのが好ましい。次いでこの混合物をオーブン或
いは熱処理炉に移し、100℃以上400℃以下の温度
で所定時間熱処理する。100℃未満では長時間でも加
熱による効果が少く、一方400℃を越えると比較的短
時間でもカルボン酸等の熱分解により、熱処理物が灰色
から黒色に着色するため、著しくその商品価値が減じら
れる。セメントの使用目的や利用するカルボン酸の種類
によって処理温度、保持時間を適宜選択するとよいが、
通常150〜250℃の温度で数時間保持することによ
り操作性の向上が十分に認められる。処理時間は0.1時
間では短すぎ、好ましくは4〜24時間である。所要の
カルボン酸量については、ガラス粉末重量に対して0.1
wt%未満ではその効果が不足であり、又10wt%を
越えるとセメント硬化体の物性に対して影響を及ぼすた
め、好ましくは0.2%以上5%以下である。A predetermined amount of such solid or liquid carboxylic acid is added to the glass powder, and both are mixed. The glass powder and the carboxylic acid can be mixed by using a V-type or ribbon-type mixer, but when the carboxylic acid is a powder, the difference in specific gravity between the powders and the difference in the starting particle size cause a sufficient mixing. For this purpose, it is preferable to use a vibration mill, a ball mill, or the like that causes shearing force or impact force. Then, this mixture is transferred to an oven or a heat treatment furnace and heat-treated at a temperature of 100 ° C. or higher and 400 ° C. or lower for a predetermined time. If it is less than 100 ° C, the effect of heating is small even for a long time, while if it exceeds 400 ° C, the heat-treated product is colored from gray to black due to thermal decomposition of carboxylic acid or the like for a relatively short time, so that its commercial value is significantly reduced. .. Depending on the purpose of use of cement and the type of carboxylic acid used, the treatment temperature and holding time may be appropriately selected,
Usually, the operability is sufficiently improved by keeping the temperature at 150 to 250 ° C for several hours. The treatment time is too short at 0.1 hours, preferably 4 to 24 hours. Regarding the amount of carboxylic acid required, it is 0.1 based on the weight of the glass powder.
If it is less than wt%, its effect is insufficient, and if it exceeds 10 wt%, it affects the physical properties of the hardened cement, so it is preferably 0.2% or more and 5% or less.
【0010】本発明におけるカルボン酸の作用の詳細は
不明であるが、ガラス表面近傍に存在するカルシウム
(Ca)等の2価アルカリ土類金属と添加したカルボン
酸が加熱により反応してある種の化合物、たとえばカル
シウム塩を生成するため、通常のポリ酸とカルシウム等
との硬化、重合反応が抑制されるためと思われる。又、
カルシウム塩の生成を検出する手段としては、少量の生
成量及び粉末表面に存在するという点から、拡散反射法
によるフーリエ変換式赤外分光分析法(DRFT−I
R)が適し、カルボン酸等の有機物の状態変化が測定で
きる。そして、本発明製法によって得られるグラスアイ
オノマーガラス粉末はDRFT−IRにおいて1700
〜1600cm-1の間に明確な吸収ピークが認められた
(図4参照)。Although the details of the action of the carboxylic acid in the present invention are not clear, there are some species in which the divalent alkaline earth metal such as calcium (Ca) existing near the glass surface and the added carboxylic acid are reacted by heating. This is probably because a compound, for example, a calcium salt is produced, and thus the curing and polymerization reaction of ordinary polyacid and calcium or the like is suppressed. or,
As a means for detecting the formation of calcium salt, a Fourier transform infrared spectroscopic analysis method (DRFT-I) by the diffuse reflection method is used because of its small amount and the presence on the powder surface.
R) is suitable, and changes in the state of organic substances such as carboxylic acids can be measured. Then, the glass ionomer glass powder obtained by the production method of the present invention is 1700 in DRFT-IR.
A clear absorption peak was observed between ˜1600 cm −1 (see FIG. 4).
【0011】[0011]
【実施例】以下、実施例及び比較例をあげて本発明をさ
らに詳しく説明する。EXAMPLES The present invention will be described in more detail with reference to Examples and Comparative Examples.
【0012】[0012]
【実施例1】X線透過法で平均粒径4.2μmのフルオ
ロアルミノシリケートガラス粉末(具体的組成(wt
%)SiO2:31,Al2O3:28,CaO:9,B
aO:11,F:12,P2O5:7,ZnO:2)に、
d-酒石酸(純度98%以上)を所定量添加し、メノー
乳鉢中で30分間乾式混合した。次いで、この混合物を
オーブンに移し、各温度で5時間加熱した後、とり出し
デシケーター中で放冷した。この熱処理ガラス粉末を市
販の硬化用ポリ酸溶液((株)松風製 登録商標ハイボ
ンドC ポリアクリル酸共重合体、酒石酸約8%入)を
用いて粉/液比1.5/1で練和し、その時のセメント
(ペースト)の操作時間をBS6039で、凝固時間を
JIS T6602に準拠して調べた。Example 1 Fluoroaluminosilicate glass powder having an average particle size of 4.2 μm by X-ray transmission method (specific composition (wt
%) SiO 2: 31, Al 2 O 3: 28, CaO: 9, B
aO: 11, F: 12, P 2 O 5: 7, ZnO: 2 in),
A predetermined amount of d-tartaric acid (purity of 98% or more) was added, and the mixture was dry-mixed for 30 minutes in a menor mortar. Then, the mixture was transferred to an oven, heated at each temperature for 5 hours, and then taken out and allowed to cool in a desiccator. This heat-treated glass powder was kneaded with a commercially available polyacid solution for curing (registered trademark, Hybond C polyacrylic acid copolymer manufactured by Matsufu Co., Ltd., containing tartaric acid at about 8%) at a powder / liquid ratio of 1.5 / 1. Then, the operation time of the cement (paste) at that time was examined with BS6039, and the coagulation time was examined according to JIS T6602.
【0013】熱処理温度及びカルボン酸(d−酒石酸)
添加量と操作時間及び凝固時間との関係を表1に示す。
なお比較例はガラス粉末を単に熱処理した(酒石酸無添
加)場合である。Heat treatment temperature and carboxylic acid (d-tartaric acid)
Table 1 shows the relationship between the added amount and the operation time and the coagulation time.
The comparative example is a case where the glass powder was simply heat-treated (without addition of tartaric acid).
【0014】[0014]
【表1】 [Table 1]
【0015】表1によれば、酒石酸無添加の比較例に比
べて、酒石酸を0.5〜5%添加して熱処理してなる実
施例試料No.1〜4の熱処理ガラス粉末は操作時間が
延長している。そして、単に室温(R.T)にて酒石酸
で処理するのに比べて、150℃〜300℃の各温度で
熱処理した場合、操作時間を更に延長できることがわか
る。According to Table 1, as compared with the comparative example in which tartaric acid was not added, 0.5 to 5% of tartaric acid was added and the sample was heat treated. The heat-treated glass powders 1 to 4 have extended operating time. Further, it can be seen that the operation time can be further extended when the heat treatment is performed at each temperature of 150 ° C. to 300 ° C., as compared with the case of simply treating with tartaric acid at room temperature (RT).
【0016】尚、凝固時間についても延長しているが、
酒石酸の添加量が多く(5.0wt%)かつ熱処理温度
が高い(300℃)場合を除いて全てJIS規格の8分
以内に収まっている。又、殆どの実施例がより好ましい
凝固時間である6分以内に収まっている。Although the coagulation time is extended,
Except when the amount of tartaric acid added is large (5.0 wt%) and the heat treatment temperature is high (300 ° C.), all are within 8 minutes of the JIS standard. In addition, most of the examples are within the more preferable coagulation time of 6 minutes.
【0017】[0017]
【実施例2】平均粒径3.5μmのフルオロアルミノシ
リケートガラス粉末(組成 SiO2:30wt%,A
l2O3:24%,SrF2:33%,AlPO4:12
%,Na2O:1%)に各種のカルボン酸を加え、25
0℃、7時間の熱処理を行った。そして、この熱処理ガ
ラス粉末を用いて上記実施例と同様に硬化用ポリ酸溶液
と練和して、セメントの操作時間及び凝固時間を調べ
た。結果を表2に示す。Example 2 Fluoroaluminosilicate glass powder having an average particle size of 3.5 μm (composition: SiO 2 : 30 wt%, A
l 2 O 3: 24%, SrF 2: 33%, AlPO 4: 12
%, Na 2 O: 1%) to which various carboxylic acids were added,
Heat treatment was performed at 0 ° C. for 7 hours. Then, this heat-treated glass powder was kneaded with a curing polyacid solution in the same manner as in the above-mentioned examples, and the operating time and setting time of the cement were examined. The results are shown in Table 2.
【0018】[0018]
【表2】 [Table 2]
【0019】表2によれば、酒石酸以外の各種カルボン
酸を添加して熱処理された熱処理ガラス粉末について
も、同様に凝固時間をJIS規格の8分以内(全ての実
施例が6分以内)に収めつつ操作時間の著しい延長が認
められた。According to Table 2, the heat treatment glass powder heat-treated by adding various carboxylic acids other than tartaric acid also had a coagulation time within 8 minutes of JIS standard (within 6 minutes in all Examples). It was confirmed that the operation time was remarkably extended while it was contained.
【0020】[0020]
【実施例3】実施例1の試料No.3及びその比較例試
料(ガラス粉末に酒石酸を添加せずに単に熱処理したも
の)について引きつづき硬化(凝固)したセメントの理
工学的性状をJIS6602に準拠して調べた。結果を
表3に示す。Third Embodiment Sample No. 1 of the first embodiment. For 3 and its comparative sample (glass powder was simply heat-treated without adding tartaric acid), the physical and engineering properties of the cured (solidified) cement were investigated in accordance with JIS6602. The results are shown in Table 3.
【0021】[0021]
【表3】 [Table 3]
【0022】表3から明らかなように、実施例試料は比
較例試料と同程度の理工学的性状を示していることがわ
かる。 因に、被膜厚さは薄ければ薄い程、接着強度が
高くなり、長持ちし、違和感がなくなり好ましいのであ
るが、この点においても実施例のガラス粉末は極めて優
れている。As can be seen from Table 3, the sample of the example shows the same physical and engineering properties as the sample of the comparative example. Incidentally, the thinner the coating thickness, the higher the adhesive strength, the longer the life and the less discomfort, which is preferable, and the glass powders of the examples are also very excellent in this respect.
【0023】[0023]
【実施例4】a)酒石酸(純度98%以上)、b)ガラ
ス粉末(実施例1の試料No.1の組成を有するも
の)、及びc)実施例1試料No.4と同様な組成を有
する酒石酸添加ガラス粉末を、 夫々ガラス製シャーレ
中で秤量し、軽くフタをした後、200℃×8時間熱処
理した。処理後の重量変化と残留物を拡散反射法フーリ
エ変換赤外分光分析(DRFT−IR)で調べた。それ
らの結果を表4及び図1〜4に示す。Example 4 a) Tartaric acid (purity of 98% or more), b) Glass powder (having the composition of Sample No. 1 of Example 1), and c) Sample No. 1 of Example 1. Tartaric acid-added glass powders having the same composition as in Example 4 were weighed in glass petri dishes, lightly capped, and then heat-treated at 200 ° C. for 8 hours. The change in weight and the residue after the treatment were examined by diffuse reflectance Fourier transform infrared spectroscopy (DRFT-IR). The results are shown in Table 4 and FIGS.
【0024】[0024]
【表4】 [Table 4]
【0025】表4より、c)実施例1試料No.4に係
る酒石酸添加ガラス粉末は、a)酒石酸単独のものに比
べて、3倍以上カルボン酸(酒石酸)が残留しているこ
とがわかる。From Table 4, c) Example 1 Sample No. It can be seen that the tartaric acid-added glass powder according to No. 4 retains carboxylic acid (tartaric acid) 3 times or more as compared with a) tartaric acid alone.
【0026】又、図1〜4はDRFT−IRの測定結果
であり、図1はa)酒石酸(常温時)、図2はa)酒石
酸(200℃×8hr熱処理後)、図3はb)がガラス
粉末(常温時:熱処理後も同じ)、そして、図4はc)
実施例1試料4と同様な組成を有する酒石酸添加ガラス
粉末(200℃×8hr熱処理後)についての結果を示
す。図3と図4との対比から明らかなように、実施例に
係る試料c)は、1700〜1600cm-1の間にCO
に基因すると思われる明確な吸収ピークが認められる。
因に、特開昭63−225567号(粉砕時にカルボン
酸を添加するが熱処理を施さないもの)では酒石酸1%
添加以上で約3300と3400cm-1に鋭い吸収ピー
クが示されているが、本実施例の試料では現われなかっ
た。1 to 4 show the results of DRFT-IR measurement. FIG. 1 shows a) tartaric acid (at room temperature), FIG. 2 a) tartaric acid (after heat treatment at 200 ° C. for 8 hours), and FIG. 3 b). Is glass powder (at room temperature: same after heat treatment), and in Fig. 4 c).
[Example 1] The results of tartaric acid-added glass powder (after heat treatment at 200 ° C for 8 hours) having the same composition as that of Sample 4 are shown. As is clear from the comparison between FIG. 3 and FIG. 4, the sample c) according to the example shows that CO is between 1700 and 1600 cm −1.
There is a clear absorption peak that is probably due to
Incidentally, in Japanese Patent Laid-Open No. 63-225567 (in which carboxylic acid is added during grinding but no heat treatment is applied), tartaric acid is 1%.
Sharp absorption peaks were shown at about 3300 and 3400 cm −1 after the addition, but they did not appear in the sample of this example.
【0027】[0027]
【実施例5】酒石酸及び実施例1試料No.4と同様の
試料である酒石酸5%添加ガラス粉末について、空気中
5℃/分で300℃まで加熱したときの状態変化(重
量、発熱、分解など)をTG−DTA(重量、示差熱分
析法)で調べた。[Example 5] Tartaric acid and Example 1 Sample No. TG-DTA (weight, differential thermal analysis method) was used to measure the state change (weight, heat generation, decomposition, etc.) of 5% tartaric acid-added glass powder, which is the same sample as in No. 4, when heated to 300 ° C at 5 ° C / min in air. ).
【0028】図5は酒石酸についてのTG−DTA曲線
である。この図5から酒石酸は約170℃まで安定に存
在し約172℃で融解することがわかる。しかし、17
5℃からTG曲線が右下りに変化し、257℃からより
急激となり、275℃以上で0となる。一方DTA曲線
は172℃で大きな吸収ピーク、すなわち吸熱ピーク
(融解)を示し、275℃で第2の吸熱ピークを示して
いる。これらのことから酒石酸単独では175℃から分
解を始め257℃で急激になり、270℃以上で消散し
てしまうことが理解される。FIG. 5 is a TG-DTA curve for tartaric acid. It can be seen from FIG. 5 that tartaric acid is stable up to about 170 ° C. and melts at about 172 ° C. But 17
The TG curve changes to the right from 5 ° C, becomes sharper from 257 ° C, and becomes 0 at 275 ° C or higher. On the other hand, the DTA curve shows a large absorption peak at 172 ° C, that is, an endothermic peak (melting), and shows a second endothermic peak at 275 ° C. From these, it is understood that tartaric acid alone starts to decompose at 175 ° C., rapidly at 257 ° C., and dissipates at 270 ° C. or higher.
【0029】図6は実施例1試料No.4と同様の試料
である酒石酸5%添加ガラス粉末についてのTG−DT
A曲線である。図5と同様、未反応の酒石酸が約175
℃で融解する。これ以上の温度では酒石酸の分解による
TG曲線の右下がり(重量減少を示す。)が明らかに見
えるが、200℃以上の分解速度は図5の場合よりも遅
くなり、300℃でも4%の重量減少(酒石酸のみの場
合5%の重量減少)であり、すなわち酒石酸が1%残
る。FIG. 6 shows the sample No. 1 of Example 1. TG-DT about 5% tartaric acid addition glass powder which is the same sample as 4
It is an A curve. As in FIG. 5, the unreacted tartaric acid is about 175.
Thaw at ℃. At temperatures above this, the TG curve shows a downward slope to the right (indicating a decrease in weight) due to the decomposition of tartaric acid, but the decomposition rate above 200 ° C is slower than in the case of Fig. 5, and even at 300 ° C the weight is 4%. A reduction (5% weight loss with tartaric acid alone), ie 1% tartaric acid remains.
【0030】従って、実施例試料の場合、高温での重量
減少速度が遅く、又300℃加熱によっても酒石酸が残
存していることがこの点よりも明らかである。Therefore, it is clear from this point that in the case of the samples of the examples, the rate of weight loss at high temperature is slow, and tartaric acid remains even after heating at 300 ° C.
【0031】[0031]
【実施例6】実施例1試料1の組成を持つ各種粒度のガ
ラス粉末100部に対し、酒石酸を5部加え、十分に乾
式混合した。次いでこの混合物を200℃、8時間化熱
処理し、粉液比1.5/1でセメントを作製し、その時
の操作時間と凝固時間を調べた(表5)。Example 6 5 parts of tartaric acid was added to 100 parts of glass powder of various particle sizes having the composition of sample 1 and thoroughly dry mixed. Next, this mixture was heat-treated at 200 ° C. for 8 hours to prepare cement at a powder / liquid ratio of 1.5 / 1, and the operation time and coagulation time at that time were examined (Table 5).
【0032】[0032]
【表5】 [Table 5]
【0033】表5によれば、各種粒度のガラス粉末につ
いて酒石酸を添加して熱処理した場合においても、同様
に凝固時間をJIS規格の8分以内に収めつつ操作時間
を著しく延長できることがわかる。According to Table 5, even when tartaric acid is added to glass powders having various particle sizes and heat treated, the operation time can be remarkably extended while keeping the coagulation time within 8 minutes of JIS standard.
【0034】[0034]
【実施例7】SiO2:26wt%,Al2O3:15
%,CaF2:23%,AlF3:12%,ZnO:12
%,AlPO4:12%の組成を持つ、平均粒径3.2
μmのガラス粉末を実施例2と同様に処理し、カルボン
酸添加の熱処理効果を調べた(表6)、尚、比較例はカ
ルボン酸を添加せずに同様に熱処理したものである。Example 7: SiO 2 : 26 wt%, Al 2 O 3 : 15
%, CaF 2 : 23%, AlF 3 : 12%, ZnO: 12
%, AlPO 4 : 12%, average particle size 3.2
A glass powder of μm was treated in the same manner as in Example 2 to examine the heat treatment effect of carboxylic acid addition (Table 6). In Comparative Example, the heat treatment was performed in the same manner without adding carboxylic acid.
【0035】[0035]
【表6】 [Table 6]
【0036】表6によれば、カルボン酸を比較的多量に
添加した場合においても、同様に凝固時間をJIS規格
の8分以内に収めつつ操作時間を著しく延長できること
がわかる。Table 6 shows that even when a relatively large amount of carboxylic acid is added, the operation time can be remarkably extended while keeping the coagulation time within 8 minutes of JIS standard.
【0037】[0037]
【発明の効果】カルボン酸を混在させて熱処理するとい
う極めて簡便な処理によって、硬化セメントの物性に殆
ど悪影響を与えることなく、グラスアイオノマーガラス
粉末の操作時間を著しく延長できる。又、用途に応じ
て、カルボン酸の種類・量或いは加熱温度・時間等を変
えることによってグラスアイオノマーガラス粉末の操作
時間や凝固時間を容易に調整できる。EFFECT OF THE INVENTION By the extremely simple treatment of mixing carboxylic acid and heat treatment, the operating time of the glass ionomer glass powder can be remarkably extended with almost no adverse effect on the physical properties of the hardened cement. Further, the operation time and the coagulation time of the glass ionomer glass powder can be easily adjusted by changing the kind and amount of the carboxylic acid or the heating temperature and time according to the application.
【図面の簡単な説明】[Brief description of drawings]
【図1】DRFT−IRスペクトル図(酒石酸:常温
時)FIG. 1 DRFT-IR spectrum diagram (tartaric acid: at room temperature)
【図2】DRFT−IRスペクトル図(酒石酸:200
℃×8hr熱処理後)FIG. 2 is a DRFT-IR spectrum diagram (tartaric acid: 200
After heat treatment at ℃ x 8 hours)
【図3】DRFT−IRスペクトル図(ガラス粉末:常
温時、熱処理後も同じ)FIG. 3 DRFT-IR spectrum diagram (glass powder: at room temperature, the same after heat treatment)
【図4】DRFT−IRスペクトル図(実施例1試料4
の組成を有する酒石酸添加ガラス粉末:200℃×8h
r熱処理後)FIG. 4 is a DRFT-IR spectrum diagram (Sample 1 of Example 1).
Glass powder with tartaric acid having the composition of 200 ° C. × 8 h
r After heat treatment)
【図5】TG−DTA曲線(酒石酸)FIG. 5 TG-DTA curve (tartaric acid)
【図6】TG−DTA曲線(実施例1試料4の組成を有
する酒石酸添加ガラス粉末)FIG. 6 TG-DTA curve (tartaric acid-added glass powder having the composition of Example 1, sample 4)
───────────────────────────────────────────────────── フロントページの続き (72)発明者 柴田 明彦 愛知県名古屋市西区則武新町三丁目1番36 号 株式会社ノリタケカンパニーリミテド 内 (72)発明者 野々川 秀樹 愛知県名古屋市西区則武新町三丁目1番36 号 株式会社ノリタケカンパニーリミテド 内 (72)発明者 中村 哲也 茨城県つくば市春日2−20−3 (72)発明者 後藤 義隆 茨城県つくば市梅園2−24−5 (72)発明者 中山 雅陽 茨城県土浦市永国1132−9 (72)発明者 増原 英一 東京都文京区本駒込2−5−11 (72)発明者 小宮 重夫 埼玉県浦和市南浦和3−7−10 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Akihiko Shibata, No. 1-36, Noritake Shinmachi, Nishi-ku, Nagoya-shi, Aichi Prefecture Noritake Company Limited Limited (72) Hideki Nonogawa 3-chome, Noritake Shin-cho, Nishi-ku, Aichi Prefecture No. 36 Noritake Company Limited Limited (72) Inventor Tetsuya Nakamura 2-20-3 Kasuga, Tsukuba City, Ibaraki Prefecture (72) Inventor Yoshitaka Goto 2-24-5 Umezono, Tsukuba City, Ibaraki Prefecture (72) Inventor Masa Nakayama Yang 1132-9, Ekuni, Tsuchiura-shi, Ibaraki Prefecture (72) Inventor Eiichi Masuhara 2-5-11, Honkomagome, Bunkyo-ku, Tokyo (72) Shigeo Komiya 3-7-10 Minamiurawa, Urawa-shi, Saitama Prefecture
Claims (6)
理することを特徴とするグラスアイオノマーセメント用
ガラス粉末の製造方法。1. A method for producing glass powder for glass ionomer cement, which comprises heat-treating a mixture of glass powder and carboxylic acid.
シル基を1から4個含むカルボン酸である請求項1に記
載の製造方法。2. The method according to claim 1, wherein the carboxylic acid for heat treatment is a carboxylic acid having 1 to 4 carboxyl groups in the molecule.
内、凝固時間5分以内である請求項1記載の製造方法。3. The method according to claim 1, wherein the glass powder before heat treatment has an operating time of 2 minutes or less and a solidification time of 5 minutes or less.
0.1〜10wt%添加する請求項1に記載の製造方
法。4. The method according to claim 1, wherein the carboxylic acid is added in an amount of 0.1 to 10 wt% based on the weight of the glass powder.
ある請求項1に記載の製造方法。5. The manufacturing method according to claim 1, wherein the heat treatment temperature is 100 ° C. or higher and 400 ° C. or lower.
リエ変換式赤外分光分析で1700〜1600cm-1の
間に明確な吸収ピークを示す請求項1に記載の製造方
法。6. The production method according to claim 1, wherein the heat-treated glass powder shows a clear absorption peak between 1700 and 1600 cm −1 by a diffuse reflection method Fourier transform infrared spectroscopic analysis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28551091A JP3378264B2 (en) | 1991-10-07 | 1991-10-07 | Method for producing glass powder for glass ionomer cement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28551091A JP3378264B2 (en) | 1991-10-07 | 1991-10-07 | Method for producing glass powder for glass ionomer cement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0597622A true JPH0597622A (en) | 1993-04-20 |
| JP3378264B2 JP3378264B2 (en) | 2003-02-17 |
Family
ID=17692465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP28551091A Expired - Lifetime JP3378264B2 (en) | 1991-10-07 | 1991-10-07 | Method for producing glass powder for glass ionomer cement |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3378264B2 (en) |
-
1991
- 1991-10-07 JP JP28551091A patent/JP3378264B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP3378264B2 (en) | 2003-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4900697A (en) | Glass powders for dental glass ionomer cements | |
| Nicholson | Chemistry of glass-ionomer cements: a review | |
| JP2742521B2 (en) | Glass ceramic containing zirconium oxide | |
| Ana et al. | Effects of added bioactive glass on the setting and mechanical properties of resin-modified glass ionomer cement | |
| JPS6267008A (en) | Fluoroaluminosilicate glass powder for dental glass ionomer cement | |
| JPS59130805A (en) | Powdery dental substance, | |
| JP2004516260A (en) | Dental inert glass | |
| JP6744399B2 (en) | Dental cement | |
| JPWO2018012352A1 (en) | Dental glass, dental composition | |
| JP5117194B2 (en) | Dental glass composition | |
| EP3205327B1 (en) | Sealer composition for root canal filling | |
| Brauer et al. | Crystallisation of fluoride-containing bioactive glasses | |
| JP2796461B2 (en) | Glass powder for glass ionomer cement and method for producing the same | |
| JP3378264B2 (en) | Method for producing glass powder for glass ionomer cement | |
| Neve et al. | Development of novel dental cements. I. Formulation of aluminoborate glasses | |
| JP2002060342A (en) | Glass ionomer-based fluorine coating material | |
| JP7716314B2 (en) | Dental glass ionomer cement composition suitable for mechanical mixing | |
| JP6734658B2 (en) | 2 Paste type root canal sealer composition | |
| EP3047839B1 (en) | Filler treated with an acidic polymer | |
| JP7679571B2 (en) | Dental glass powder and dental composition | |
| JPS62153204A (en) | Root canal filling material for dental use | |
| JPH02275731A (en) | Glass powder for glass ionomer cement | |
| JPH0248479A (en) | Method for curing curable composition | |
| JP3450059B2 (en) | Glass powder for dental cement | |
| JP5653555B1 (en) | Two-component mixed ion sustained release mucosal preparation composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20021119 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071206 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081206 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081206 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091206 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091206 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101206 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111206 Year of fee payment: 9 |
|
| EXPY | Cancellation because of completion of term |